Chemoinformaics analysis of (+)-MEDIORESINOL-DI-O-BETA-D-GLUCOPYRANOSIDE
| Molecular Weight | 712.698 | nRot | 11 |
| Heavy Atom Molecular Weight | 668.346 | nRig | 33 |
| Exact Molecular Weight | 712.258 | nRing | 6 |
| Solubility: LogS | -2.5 | nHRing | 4 |
| Solubility: LogP | -1.043 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 50 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 12 |
| nHA | 17 | APOL | 98.0829 |
| nHD | 8 | BPOL | 59.7651 |
| QED | 0.127 |
| Synth | 5.172 |
| Natural Product Likeliness | 1.213 |
| NR-PPAR-gamma | 0.046 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.986 |
| HIA | 0.959 |
| CACO-2 | -6.373 |
| MDCK | 0.000166755 |
| BBB | 0.243 |
| PPB | 0.253774 |
| VDSS | 0.404 |
| FU | 0.333262 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.079 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.676 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.147 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.232 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.069 |
| CL | 1.182 |
| T12 | 0.079 |
| hERG | 0.059 |
| Ames | 0.115 |
| ROA | 0.104 |
| SkinSen | 0.009 |
| Carcinogencity | 0.161 |
| EI | 0.003 |
| Respiratory | 0.003 |
| NR-Aromatase | 0.729 |
| Antiviral | Yes |
| Prediction | 0.896524 |